E
Eikon Therapeutics Inc
NASDAQ:EIKN
Eikon Therapeutics Inc
NASDAQ:EIKN
Price:
9.01
USD
-5.16%
Market Closed
Market Cap:
$487.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
E
|
Eikon Therapeutics Inc
NASDAQ:EIKN
|
US |
Income Statement
Earnings Waterfall
Eikon Therapeutics Inc
Eikon Therapeutics Inc
Income Statement
Eikon Therapeutics Inc
Eikon Therapeutics Inc
Currency: USD
| Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|
| Revenue | ||||
| Interest Expense |
0
|
0
|
1
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||
| Operating Expenses |
(266)
|
(260)
|
(339)
|
|
| Selling, General & Administrative |
(58)
|
(56)
|
(89)
|
|
| Research & Development |
(207)
|
(205)
|
(250)
|
|
| Operating Income |
(266)
N/A
|
(260)
+2%
|
(339)
-30%
|
|
| Pre-Tax Income | ||||
| Interest Income Expense |
24
|
17
|
15
|
|
| Total Other Income |
0
|
(0)
|
(0)
|
|
| Pre-Tax Income |
(242)
N/A
|
(244)
-1%
|
(324)
-33%
|
|
| Net Income | ||||
| Income from Continuing Operations |
(242)
|
(244)
|
(324)
|
|
| Net Income (Common) |
(242)
N/A
|
(244)
-1%
|
(334)
-37%
|
|
| EPS (Diluted) |
-4.48
N/A
|
-4.52
-1%
|
-6.18
-37%
|
|
Switch to:
Switch to:
See Also
Discover More
